Application of robot-assisted radical prostatectomy in men over 75 years: an analysis of comparative outcomes

References

• Gandaglia G, Leni R, Bray F, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877–892.
   PubMed Web of Science ®Google Scholar
• Gurung PMS, Wang B, Hassig S, et al. Oncological and functional outcomes in patients over 70 years of age treated with robotic radical prostatectomy: a propensity-matched analysis. World J Urol. 2021;39(4):1131–1140.
   PubMed Web of Science ®Google Scholar
• Garisto J, Bertolo R, Wilson CA, et al. The evolution and resurgence of perineal prostatectomy in the robotic surgical era. World J Urol. 2020;38(4):821–828.
   PubMed Web of Science ®Google Scholar
• Du Y, Long Q, Guan B, et al. Robot-assisted radical prostatectomy is more beneficial for prostate cancer patients: a system review and meta-analysis. Med Sci Monit. 2018;24:272–287.
   PubMed Web of Science ®Google Scholar
• Basiri A, de la Rosette JJ, Tabatabaei S, et al. Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner? World J Urol. 2018;36(4):609–621.
   PubMed Web of Science ®Google Scholar
• Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243–262.
   PubMed Web of Science ®Google Scholar
• Schaeffer E, Srinivas S, Antonarakis ES, et al. NCCN guidelines insights: prostate cancer, version 1.2021. J Natl Compr Canc Netw. 2021;19(2):134–143.
   PubMed Web of Science ®Google Scholar
• Leyh-Bannurah SR, Wagner C, Schuette A, et al. Feasibility of robot-assisted radical prostatectomy in men at senior age ≥75 years: perioperative, functional, and oncological outcomes of a high-volume center. Aging Male. 2022;25(1):8–16.
   PubMed Web of Science ®Google Scholar
• Mandel P, Kriegmair MC, Kamphake JK, et al. Tumor characteristics and oncologic outcome after radical prostatectomy in men 75 years old or older. J Urol. 2016;196(1):89–94.
   PubMed Web of Science ®Google Scholar
• Carbin DD, Tamhankar AS, Ahluwalia P, et al. Robot-assisted radical prostatectomy in Indian men of age 75 years and above: a propensity score-matched analysis. J Robot Surg. 2022;16(4):799–806.
   PubMedGoogle Scholar
• Bellera CA, Rainfray M, Mathoulin-Pélissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–2172.
   PubMed Web of Science ®Google Scholar
• Nakamura LY, Nunez RN, Andrews PE, et al. Older age does not impact perioperative complications after robot-assisted radical prostatectomy. J Robot Surg. 2011;5(3):201–208.
   PubMedGoogle Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
   PubMedGoogle Scholar
• Porres D, Pfister D, Labanaris AP, et al. [Robot-assisted radical prostatectomy in elderly patients: surgical, oncological and functional outcomes]. Urologe A. 2012;51(10):1424–1431.
   PubMedGoogle Scholar
• Sasaki Y, Shiozaki K, Miyake T, et al. [ROBOT-assisted radical prostatectomy for men age 75 and older]. Nihon Hinyokika Gakkai Zasshi. 2017;108(1):12–16.
   PubMedGoogle Scholar
• Ubrig B, Boy A, Heiland M, et al. Outcome of robotic radical prostatectomy in men over 74. J Endourol. 2018;32(2):106–110.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Teshima T, Fujimura T, et al. Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy. PLoS One. 2020;15(6):e0234113.
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Watanabe H, Kurahashi T. Safety and feasibility of robot-assisted radical prostatectomy for clinically localized prostate cancer in elderly Japanese patients. Prostate Int. 2017;5(1):13–16.
   PubMed Web of Science ®Google Scholar
• Cornelius J, Mudlagk J, Afferi L, et al. Postoperative peripheral neuropathies associated with patient positioning during robot-assisted laparoscopic radical prostatectomy (RARP): a systematic review of the literature. Prostate. 2021;81(7):361–367.
   PubMed Web of Science ®Google Scholar
• Alibhai SM, Naglie G, Nam R, et al. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol. 2003;21(17):3318–3327.
   PubMed Web of Science ®Google Scholar
• Greco KA, Meeks JJ, Wu S, et al. Robot-assisted radical prostatectomy in men aged > or =70 years. BJU Int. 2009;104(10):1492–1495.
   PubMed Web of Science ®Google Scholar
• Togashi K, Hatakeyama S, Okamoto T, et al. Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years. Urol Oncol. 2021;39(10):729.e17–729.e25.
   PubMed Web of Science ®Google Scholar
• Gu X, Araki M, Wong C. Does elevated body mass index (BMI) affect the clinical outcomes of robot-assisted laparoscopic prostatectomy (RALP): a prospective cohort study. Int J Surg. 2014;12(10):1055–1060.
   PubMed Web of Science ®Google Scholar
• Fossati N, Willemse PM, Van den Broeck T, et al. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol. 2017;72(1):84–109.
   PubMed Web of Science ®Google Scholar
• Scosyrev E, Messing EM, Mohile S, et al. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer. 2012;118(12):3062–3070.
   PubMedGoogle Scholar
• Zorn KC, Mendiola FP, Rapp DE, et al. Age-stratified outcomes after robotic-assisted laparoscopic radical prostatectomy. J Robot Surg. 2007;1(2):125–132.
   PubMedGoogle Scholar
• Li J, Li Y, Cao D, et al. Outpatient versus inpatient robot-assisted radical prostatectomy: an evidence-based analysis of comparative outcomes. J Endourol. 2022;36(4):468–476.
   PubMed Web of Science ®Google Scholar
• Singh R, Hicks JA. Robot-assisted radical prostatectomy in men aged > or =70 years (comment on Greco KA, Meeks JJ, Wu S, Nadler RB. BJU Int. 2009 Nov;104(10):1492–5.)
   Google Scholar
• Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'cologne male survey. Int J Impot Res. 2000;12(6):305–311.
   PubMed Web of Science ®Google Scholar
• Verdú E, Ceballos D, Vilches JJ, et al. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst. 2000;5(4):191–208.
   PubMed Web of Science ®Google Scholar
• Seppan P, Muhammed I, Mohanraj KG, et al. Therapeutic potential of Mucuna pruriens (Linn.) on ageing induced damage in dorsal nerve of the penis and its implication on erectile function: an experimental study using albino rats. Aging Male. 2020;23(5):313–326.
   PubMed Web of Science ®Google Scholar
• Brassell SA, Rice KR, Parker PM, et al. Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes. J Urol. 2011;185(1):132–137.
   PubMed Web of Science ®Google Scholar
• Yassin A, AlRumaihi K, Alzubaidi R, et al. Testosterone, testosterone therapy and prostate cancer. Aging Male. 2019;22(4):219–227.
   PubMed Web of Science ®Google Scholar
• Efesoy O, Apa D, Tek M, et al. The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism. Aging Male. 2016;19(2):79–84.
   PubMed Web of Science ®Google Scholar
• Ferro M, Lucarelli G, Bruzzese D, et al. Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance. Oncotarget. 2017;8(11):18424–18434.
   PubMedGoogle Scholar
• Ferro M, Lucarelli G, de Cobelli O, et al. Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with international society of urological pathology grade group 1 prostate cancer diagnosed with systematic biopsies. World J Urol. 2021;39(6):1861–1867.
   PubMed Web of Science ®Google Scholar